Zimmerman G A, McIntyre T M, Prescott S M
J Clin Invest. 1985 Dec;76(6):2235-46. doi: 10.1172/JCI112232.
Highly purified human thrombin stimulates the adherence of polymorphonuclear leukocytes (PMNs) to vascular endothelial cells (EC). When Indium-labeled PMNs were incubated with primary monolayers of cultured human umbilical vein EC, the basal adherence was 10 +/- 1% of the PMNs at 5 min. Addition of thrombin (2 U/ml) increased the mean adherence to 42 +/- 15%. Enhanced neutrophil adherence in response to thrombin was confirmed by experiments with unlabeled leukocytes, examined by phase contrast and scanning electron microscopy. The action of thrombin was on the EC, since it did not directly stimulate PMN adhesiveness when measured by aggregation or by adherence to nylon fiber columns. Furthermore, enhanced neutrophil adherence occurred when endothelial monolayers were treated with thrombin and washed before adding 111Indium (111In)-labeled PMNs. Thrombin that had been inactivated with antithrombin III and heparin did not enhance neutrophil adherence. Prothrombin, Factor Xa, and fibrinogen were also ineffective. The stimulated adherence of PMNs was maximal 5 min after incubation of the EC with thrombin, and decreased thereafter. The response was dose-dependent, with half-maximal stimulation at 0.2-0.25 U thrombin/ml. The enhanced PMN adherence caused by thrombin may result in part from the production of platelet-activating factor (PAF) by the stimulated EC since thrombin-stimulated EC synthesize PAF with a time course and concentration dependence that are similar to the time and concentration relationships for thrombin-stimulated PMN adherence, PAF itself promoted neutrophil adherence to the EC monolayers, and pretreatment of PMNs with PAF decreased the adherence stimulated by thrombin and PAF, but not adherence stimulated by N-formylmethionyl-leucyl-phenylalanine and C5a fragments, which indicates specific desensitization of PAF-mediated adherence. These studies demonstrate the endothelial cell-dependent stimulation of PMN adherence by thrombin, a novel mechanism of enhanced leukocyte adherence that may be important in interactions between the coagulation and inflammatory systems.
高度纯化的人凝血酶可刺激多形核白细胞(PMN)与血管内皮细胞(EC)的黏附。当用铟标记的PMN与培养的人脐静脉EC原代单层细胞一起孵育时,5分钟时基础黏附率为PMN的10±1%。加入凝血酶(2 U/ml)后,平均黏附率增加到42±15%。通过用未标记白细胞进行实验,并通过相差显微镜和扫描电子显微镜检查,证实了凝血酶刺激后中性粒细胞黏附增强。凝血酶的作用是作用于EC,因为通过聚集或对尼龙纤维柱的黏附测量时,它不会直接刺激PMN的黏附性。此外,当用凝血酶处理内皮单层细胞并在加入铟-111(111In)标记的PMN之前洗涤时,中性粒细胞黏附增强。用抗凝血酶III和肝素灭活的凝血酶不会增强中性粒细胞黏附。凝血酶原、因子Xa和纤维蛋白原也无效。EC与凝血酶孵育5分钟后,PMN的刺激黏附达到最大值,此后降低。该反应呈剂量依赖性,在0.2 - 0.25 U/ml凝血酶时刺激达到最大值的一半。凝血酶引起的PMN黏附增强可能部分是由于受刺激的EC产生血小板活化因子(PAF),因为凝血酶刺激的EC合成PAF的时间进程和浓度依赖性与凝血酶刺激的PMN黏附的时间和浓度关系相似,PAF本身促进中性粒细胞与EC单层的黏附,用PAF预处理PMN可降低凝血酶和PAF刺激的黏附,但不能降低N-甲酰甲硫氨酰-亮氨酰-苯丙氨酸和C5a片段刺激的黏附,这表明PAF介导的黏附存在特异性脱敏。这些研究证明了凝血酶对PMN黏附的内皮细胞依赖性刺激,这是一种增强白细胞黏附的新机制,可能在凝血系统和炎症系统的相互作用中起重要作用。